A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis-Reference-Cited by-同舟云学术

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis

Published:2015-10-27 Issue:11 Volume:67 Page:1503-1512
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Burgos‐Vargas Rubén¹,Tse Shirley M. L.²,Horneff Gerd³,Pangan Aileen L.⁴,Kalabic Jasmina⁵,Goss Sandra⁴,Unnebrink Kristina⁵,Anderson Jaclyn K.⁴

Affiliation:

1. Hospital General de Mexico, Universidad Nacional Autonoma de MexicoMexico City Mexico

2. The Hospital for Sick Children, University of Toronto Toronto Ontario Canada

3. Asklepios Klinik Sankt Augustin Sankt Augustin Germany

4. AbbVie North Chicago Illinois

5. AbbVie Deutschland Ludwigshafen Germany

Funder

AbbVie

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.22657

Reference41 articles.

1. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty RE;J Rheumatol,2004

2. Long-term outcome and prognostic factors in enthesitis-related arthritis: A case–control study

3. Outcome in patients with enthesitis related arthritis (ERA): juvenile arthritis damage index (JADI) and functional status

4. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis

5. Pain Intensity Variability and Its Relationship With Quality of Life in Youths With Juvenile Idiopathic Arthritis

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-inflicted very-low-velocity penetrating head injury: A CARE-compliant case report;Medicine;2024-05-03

2. Comparative efficacy and safety of different drugs in patients with systemic juvenile idiopathic arthritis: A systematic review and network meta-analysis;Medicine;2024-05-03

3. Drug therapy in juvenile spondyloarthritis;Current Opinion in Rheumatology;2024-04-22

4. Treatment of non-systemic juvenile idiopathic arthritis;Nature Reviews Rheumatology;2024-02-06

5. Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases;Pediatric Rheumatology;2024-01-02